Search

everythinglearnresearchcommunity

for

Search:↓

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

Minoxidil helps regrow hair in female pattern hair loss, but more research needed for other treatments.

Hair loss requires customized treatments based on its various causes and types.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Using a special stem cell formula on the scalp once a month for six months helped people with hair loss grow more hair.

Low-level light therapy safely improves hair coverage, thickness, and count in androgenetic alopecia patients.

PRP therapy may improve skin and hair conditions, but more research with standard methods is needed.

Parietal scalp area has lower hair density and smaller hair diameter in women with hair loss.

Polyamines are important for hair growth, but more research is needed to understand their functions and treatment potential.

PRP treatment helps hair growth and density with 70.7% success, but more research needed.

The Cross-section Trichometer is a new tool that can measure hair quantity and detect hair loss and growth.

Platelet-Rich Plasma (PRP) treatment may increase hair growth for genetic hair loss, but more research is needed to confirm this.

PRP injections help regrow hair, reduce hair loss, and increase hair thickness, but effects decrease without ongoing treatment.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

The marine complex supplement significantly improved hair growth in men with thinning hair without adverse effects.

Scalp microneedling may improve hair density and thickness for various alopecia types.

PRP injections effectively promote hair growth in androgenetic alopecia patients.

Multimodal minoxidil microemulsion is more effective in treating hair loss than minoxidil alone.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Minoxidil 2% effectively treats Monilethrix without side effects.

Topical cetirizine improves hair density and thickness in androgenetic alopecia, but more research is needed.

Using micro-needling, low-level laser therapy, and platelet-rich plasma together significantly improves hair growth in people with hair loss.

SVF-PRP therapy effectively reverses hair loss effects.

Methyl vanillate spray increases hair count and hair mass in women with hair loss.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

Platelet-rich plasma injections significantly improve hair density and thickness in both male and female pattern hair loss, especially in early stages.

Combining platelet-rich plasma with 5% minoxidil solution improves hair regrowth in androgenetic alopecia patients.

Moderately high prolactin levels do not cause hair loss in women.

The QR 678 hair growth treatment was safe and effective for hair regrowth in men and women.